Lawrence E. Crane

Array ( [id] => 5496613 [patent_doc_number] => 20090264641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'METHOD FOR THE ISOLATION OF MRNA FROM FORMALIN FIXED, PARAFFIN-EMBEDDED TISSUE' [patent_app_type] => utility [patent_app_number] => 12/090767 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4843 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264641.pdf [firstpage_image] =>[orig_patent_app_number] => 12090767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196148 [patent_doc_number] => 07635690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine' [patent_app_type] => utility [patent_app_number] => 11/542044 [patent_app_country] => US [patent_app_date] => 2006-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13269 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635690.pdf [firstpage_image] =>[orig_patent_app_number] => 11542044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6607916 [patent_doc_number] => 20100063268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'NUCLEIC ACID EXTRACTION METHOD' [patent_app_type] => utility [patent_app_number] => 11/993352 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23822 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063268.pdf [firstpage_image] =>[orig_patent_app_number] => 11993352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113304 [patent_doc_number] => 08569478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Modified 4′-nucleosides as antiviral agents' [patent_app_type] => utility [patent_app_number] => 12/067995 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10300 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12067995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803321 [patent_doc_number] => 07423025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'L-nucleosides as ligands to adenosine receptors' [patent_app_type] => utility [patent_app_number] => 11/517977 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 13435 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423025.pdf [firstpage_image] =>[orig_patent_app_number] => 11517977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7595581 [patent_doc_number] => 07625879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Phosphohalohydrins, process for the production thereof and use thereof' [patent_app_type] => utility [patent_app_number] => 11/512688 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9991 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625879.pdf [firstpage_image] =>[orig_patent_app_number] => 11512688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142454 [patent_doc_number] => 20070004670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Compositions containing citicoline, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/510737 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 28763 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004670.pdf [firstpage_image] =>[orig_patent_app_number] => 11510737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688960 [patent_doc_number] => 20060287275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Partial and full agonists of A1 adenosine receptors' [patent_app_type] => utility [patent_app_number] => 11/510550 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14775 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287275.pdf [firstpage_image] =>[orig_patent_app_number] => 11510550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505341 [patent_doc_number] => 07202224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase' [patent_app_type] => utility [patent_app_number] => 11/496338 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57231 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202224.pdf [firstpage_image] =>[orig_patent_app_number] => 11496338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733496 [patent_doc_number] => 20060258613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Nucleoside derivatives for treating hepatitis C virus infection' [patent_app_type] => utility [patent_app_number] => 11/492558 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11858 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258613.pdf [firstpage_image] =>[orig_patent_app_number] => 11492558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682893 [patent_doc_number] => 20080249119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Homogemcitabines' [patent_app_type] => utility [patent_app_number] => 11/996203 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5686 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249119.pdf [firstpage_image] =>[orig_patent_app_number] => 11996203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4604760 [patent_doc_number] => 07985740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-26 [patent_title] => 'Purine derivatives as agonists of the adenosine A2A receptor' [patent_app_type] => utility [patent_app_number] => 11/995921 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16928 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/985/07985740.pdf [firstpage_image] =>[orig_patent_app_number] => 11995921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 892169 [patent_doc_number] => 07345028 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-18 [patent_title] => 'Energy-protective composition comprising adenosine phosphates' [patent_app_type] => utility [patent_app_number] => 11/483659 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4804 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/345/07345028.pdf [firstpage_image] =>[orig_patent_app_number] => 11483659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662107 [patent_doc_number] => 20060252703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method for treating cancer' [patent_app_type] => utility [patent_app_number] => 11/480657 [patent_app_country] => US [patent_app_date] => 2006-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8384 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252703.pdf [firstpage_image] =>[orig_patent_app_number] => 11480657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120602 [patent_doc_number] => 20070142317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Topical composition for treatment of skin disorders' [patent_app_type] => utility [patent_app_number] => 11/478362 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 60239 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142317.pdf [firstpage_image] =>[orig_patent_app_number] => 11478362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924037 [patent_doc_number] => 20060241065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Ring-expanded nucleosides and nucleotides' [patent_app_type] => utility [patent_app_number] => 11/472395 [patent_app_country] => US [patent_app_date] => 2006-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32785 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241065.pdf [firstpage_image] =>[orig_patent_app_number] => 11472395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693855 [patent_doc_number] => 20070015831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Diclofenac formulations and methods of use' [patent_app_type] => utility [patent_app_number] => 11/455120 [patent_app_country] => US [patent_app_date] => 2006-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12209 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015831.pdf [firstpage_image] =>[orig_patent_app_number] => 11455120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5601685 [patent_doc_number] => 20060292030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Process for the preparation of sterile polysaccharide solutions' [patent_app_type] => utility [patent_app_number] => 11/453250 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5098 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292030.pdf [firstpage_image] =>[orig_patent_app_number] => 11453250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425275 [patent_doc_number] => 07271258 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Methods of synthesizing oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection' [patent_app_type] => utility [patent_app_number] => 11/453734 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12077 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271258.pdf [firstpage_image] =>[orig_patent_app_number] => 11453734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 864861 [patent_doc_number] => 07368439 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Dinucleoside poly(borano)phosphate derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/452244 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11790 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368439.pdf [firstpage_image] =>[orig_patent_app_number] => 11452244 [rel_patent_id] =>[rel_patent_doc_number] =>)